These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 522906
1. 4,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man. Bässmann H, Böttcher J, Schüppel R. Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):203-5. PubMed ID: 522906 [Abstract] [Full Text] [Related]
2. Quantitation and urinary pattern of 4,4'-dihydroxy-antipyrine, 4-hydroxy-antipyrine and 3-hydroxymethyl-antipyrine, as main metabolites of antipyrine in man and rat. Böttcher J, Bässmann H, Schüppel R. J Pharm Pharmacol; 1982 Mar; 34(3):168-75. PubMed ID: 6121894 [Abstract] [Full Text] [Related]
3. Metabolism of antipyrine by the epoxide-diol pathway in the rat, guinea pig and human. Stafford M, Kellermann G, Stillwell RN, Horning MG. Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):593-606. PubMed ID: 4418208 [No Abstract] [Full Text] [Related]
4. [On the metabolism of antipyrine (phenazone) in man (author's transl)]. Zietz E, Eichelbaum M, Dengler HJ, Spiteller G. Arzneimittelforschung; 1978 Aug; 28(2):315-9. PubMed ID: 580401 [Abstract] [Full Text] [Related]
5. Species- and sex-related differences in the plasma clearance and metabolite formation of antipyrine. A comparative study in four animal species: cattle, goat, rat and rabbit. Witkamp RF, Lohuis JA, Nijmeijer SM, Kolker HJ, Noordhoek J, van Miert AS. Xenobiotica; 1991 Nov; 21(11):1483-92. PubMed ID: 1763522 [Abstract] [Full Text] [Related]
6. Phenazone metabolism during perfusion of isolated guinea pig liver. Tarnawski A, Goszcz A, Bogdał J, Barylak H, Mach T. Pol J Pharmacol Pharm; 1978 Nov; 30(5):621-6. PubMed ID: 751005 [Abstract] [Full Text] [Related]
7. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat. Böttcher J, Bässmann H, Schüppel R. J Pharm Pharmacol; 1984 Jun; 36(6):391-8. PubMed ID: 6146671 [Abstract] [Full Text] [Related]
8. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration. Eichelbaum M, Ochs HR, Roberts G, Somogyi A. Arzneimittelforschung; 1982 Jun; 32(5):575-8. PubMed ID: 7201837 [Abstract] [Full Text] [Related]
9. Preparative isolation and purification of urinary conjugates in antipyrine metabolism in man and rat. Böttcher J, Bässmann H, Schüppel R, Lehmann WD. Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):226-33. PubMed ID: 7155204 [Abstract] [Full Text] [Related]
18. Studies on metabolism of bromazepam. VI. Reduction of 2-(2-amino-5-bromobenzoyl)pyridine, a metabolite of bromazepam, in the rabbit, rat, and guinea pig. Sawada H, Hara A. Drug Metab Dispos; 1978 Dec; 6(3):205-12. PubMed ID: 26538 [Abstract] [Full Text] [Related]
19. The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation. Meredith PA, Campbell BC, Moore MR, Goldberg A. Eur J Clin Pharmacol; 1977 Nov 14; 12(3):235-9. PubMed ID: 412677 [Abstract] [Full Text] [Related]
20. Investigation of the microbial degradation of phenazone-type drugs and their metabolites by natural biofilms derived from river water using liquid chromatography/tandem mass spectrometry (LC-MS/MS). Pieper C, Risse D, Schmidt B, Braun B, Szewzyk U, Rotard W. Water Res; 2010 Aug 14; 44(15):4559-69. PubMed ID: 20619430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]